Dr. Tezel replaces Peter Shen, PhD, who retired, according to a Nov. 7 company news release shared with Becker’s. In his role, he will be responsible for end-to-end elements of reserach and development for the company.
He previously worked as vice president of R&D at Ethicon.
Johnson & Johnson MedTech includes orthopedic technology. The company named Kurt Van den Bosch as CFO in May.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.